Prof. Dr. ZAFER SEZER

Yayın Ağı

Makaleler 25

1. Bioequivalence and Pharmacokinetics of Low-Dose Anagrelide 0.5 mg Capsules in Healthy Volunteers

İNAL A., SEZER Z., Pinarbasli O., Bulut B., Reinsch M., Martin W., et al.

Biomedicines , cilt.13, sa.8, 2025 (SCI-Expanded, Scopus)

2. Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months

YILMAZ S., EKEN A., SEZER Z., Bagci B. S., Erdem S., Sarikaya M. D., et al.

FRONTIERS IN MEDICINE , cilt.12, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Bioequivalence study of eltrombopag 75 mg film-coated tablets under fasting conditions during the Covid-19 pandemic in healthy Caucasian male subjects

İNAL A., SEZER Z., Pinarbasli O., Bulut B., Reinsch M., Martin W., et al.

BMC Pharmacology and Toxicology , cilt.25, sa.1, 2024 (SCI-Expanded, Scopus)

4. Bioequivalence study of low dose drospirenone/ethinyl estradiol 3 mg/0.03 mg film tablets under fasting conditions in Turkish healthy female subjects

İNAL A., SEZER Z., Uluozlu B., Oflas M., Reinsch M., Martin W., et al.

PHARMACOLOGY RESEARCH & PERSPECTIVES , cilt.12, sa.4, 2024 (SCI-Expanded, Scopus)

5. Bioequivalence Study of Capsules versus Film Tablets Containing Rivaroxaban in Healthy Caucasian Subjects under Fasting and Fed Conditions

Sözer G., İNAL A., SEZER Z., Martin W., Ottmann E., Reinsch M., et al.

Clinical Pharmacology in Drug Development , cilt.13, sa.3, ss.281-287, 2024 (SCI-Expanded, Scopus)

6. Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up

Sezer Z., Pavel S. T. I., Inal A., Yetiskin H., Kaplan B., Uygut M. A., et al.

VACCINES , cilt.12, sa.2, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Safety and Efficacy of a Novel Combination Cream (GN-037) in Healthy Volunteers and Patients with Plaque Psoriasis: A Phase 1 Trial

SEZER Z., İNAL A., ÇINAR S. L., MAZICIOĞLU M. M., Altug S., KARASULU H. Y., et al.

Dermatology and Therapy , cilt.13, sa.7, ss.1489-1501, 2023 (SCI-Expanded, Scopus)

8. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

Ates I., Batirel A., Aydin M., Karadag F. Y., Erden A., KÜÇÜKŞAHİN O., et al.

Vaccines , cilt.11, sa.7, 2023 (SCI-Expanded, Scopus)

9. Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III Trial

DURUSU TANRIÖVER M., Aydin O. A., Guner R., YILDIZ O., Celik I., Doganay H. L., et al.

VACCINES , cilt.10, sa.11, 2022 (SCI-Expanded, Scopus)

10. Indomethacin prevents TGF-beta-induced epithelial-to-mesenchymal transition in pancreatic cancer cells; evidence by Raman spectroscopy

SEZER G., ÖNSES M. S., ŞAKİR M., Sahin F., camdal A., SEZER Z., et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY , cilt.280, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Turkey: A randomized trial

Omma A., Batirel A., Aydin M., Karadag F. Y., Erden A., KÜÇÜKŞAHİN O., et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS , cilt.18, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Akılcı İlaç Kullanımı ve Farmakoekonomi

SEZER Z.

J Fam Med-Special Topic , cilt.8, sa.3, ss.224-230, 2017 (TRDizin)

13. Abstracts

SEZER G., Tekol Y., SEZER Z.

Pain Practice , cilt.16, ss.6-176, 2016 (SCI-Expanded, Scopus)

14. Klinik Araştırmalarda Araştırmacı Olmak

SEZER Z., ERENMEMİŞOĞLU A.

Türkiye Klinikleri Farmakoloji , cilt.4, sa.2, 2016 (TRDizin)

15. Involvement of adenosine receptors in the anticonvulsant effect of agmatine in mice

SEZER Z., Erçal Ö., Kara M.

EUROPEAN NEUROPSYCHOPHARMACOLOGY , sa.24, ss.260, 2014 (SCI-Expanded, Scopus)

16. Biyobenzer İlaçlar Biosimilar Drugs

NACAK M., SEZER Z., ERENMEMİŞOĞLU A.

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE , cilt.3, sa.2, ss.251-256, 2012 (TRDizin)

17. Ephedrine enhances the antinociceptive effect of dexmedetomidine in mice

SEZER Z., Sezer G., Tekol Y.

NEUROENDOCRINOLOGY LETTERS , cilt.32, sa.4, ss.552-556, 2011 (SCI-Expanded, Scopus)

18. Ephedrine enhances the antinociceptive effect of dexmedetomidine in mice

SEZER Z., SEZER G., TEKOL Y.

Neuro Endocrinol Lett. , cilt.32, ss.552-556, 2011 (SCI-Expanded)

19. Mirtazapine does not affect pentylenetetrazole- and maximal electroconvulsive shock-induced seizures in mice

Yilmaz I., Sezer Z., Kayir H., Uzbay T. I.

EPILEPSY & BEHAVIOR , cilt.11, sa.1, ss.1-5, 2007 (SCI-Expanded, Scopus)

20. Farede akut ağrı modelinde sertralinin oluşturduğu antinosiseptif cevaba kafeinin etkisi

SEZER Z., SEZER G.

Erciyes Üniversitesi Sağlık Bilimleri Dergisi , sa.16, ss.56-61, 2007 (Hakemli Dergi)

21. Interaction between venlafaxine and caffeine on antinociception in mice

Yaba G., SEZER Z., TEKOL Y.

PHARMAZIE , cilt.61, sa.1, ss.60-62, 2006 (SCI-Expanded, Scopus)

22. Comparing the relaxing effects of desflurane and sevoflurane on oxytocin-induced contractions of isolated myometrium in both pregnant and nonpregnant rats

GULTEKIN H., Yildiz K., SEZER Z., DOGRU K.

ADVANCES IN THERAPY , cilt.23, sa.1, ss.39-46, 2006 (SCI-Expanded, Scopus)

23. Inhibitory effects of desflurane and sevoflurane on oxytocin-induced contractions of isolated pregnant human myometrium

YILDIZ K., DOGRU K., DALGIC H., SERIN I. S., SEZER Z., Madenoglu H., et al.

ACTA ANAESTHESIOLOGICA SCANDINAVICA , cilt.49, sa.9, ss.1355-1359, 2005 (SCI-Expanded, Scopus)

24. The direct depressant effects of desflurane and sevoflurane on spontaneous contractions of isolated gravid rat myometrium

DOGRU K., DALGIC H., YILDIZ K., SEZER Z., Madenoglu H.

INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA , cilt.12, sa.2, ss.74-78, 2003 (SCI-Expanded, Scopus)

25. Inhibitory effects of desflurane and sevoflurane on contractions of isolated gravid rat myometrium under oxytocin stimulation

DOGRU K., YILDIZ K., DALGIC H., Sezer Z., Yaba G., MADENOGLU H.

ACTA ANAESTHESIOLOGICA SCANDINAVICA , cilt.47, sa.4, ss.472-474, 2003 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 22

1. İNAKTİF COVID-19 AŞISI TURKOVAC’IN UZUN SÜRELİ BAĞIŞIKLIK ETKİLERİ: SPIKE PROTEİNİNE ÖZGÜ B HÜCRE YANITLARININ KARAKTERİZASYONU

BAĞCI B. Ş., YILMAZ S., EKEN A., ERDEM Ş., Doğan Sarıkaya M., SEZER Z., et al.

5. Uluslararası Aşı Bilimi Kongresi, Kayseri, Türkiye, 16 - 18 Ekim 2024, ss.61, (Özet Bildiri)

2. TURKOVAC İNAKTİF COVID-19 AŞISININ HÜCRESEL VE HUMORAL BAĞIŞIKLIK HAFIZASI ÜZERİNDEKİ UZUN DÖNEM ETKİLERİNİN ARAŞTIRILMASI

BAĞCI B. Ş., YILMAZ S., EKEN A., ERDEM Ş., Doğan Sarıkaya M., SEZER Z., et al.

5. Uluslararası Aşı Bilimi Kongresi, Kayseri, Türkiye, 16 - 18 Ekim 2024, ss.17, (Özet Bildiri)

3. Peripheral antinociceptive effect of venlafaxine in rats

SEZER G., Tekol Y., SEZER Z.

2017 PNS Annual Meeting, İspanya, 8 - 12 Temmuz 2017, cilt.22, ss.226-414, (Özet Bildiri)

4. Antidepressant drug venlafaxine has peripheral antinociceptive effect

SEZER G., Tekol Y., SEZER Z.

4th International Symposium on Peripheral Nerve Regeneration, Barselona, İspanya, 6 - 08 Temmuz 2017, (Özet Bildiri)

5. Phase 1 bioequivalency studies of neuropathic pain medications

SEZER Z.

4th International Symposium on Peripheral Nerve Regeneration, Barselona, İspanya, 6 - 08 Temmuz 2017, (Özet Bildiri)

6. Role of Adenosine And Adenosine A2A Receptors in the Antidepressant Effectof Amitriptyline

SEZER G., SEZER Z.

9th International Congress onPsychopharmacology 5th InternationalSymposium on Child and AdolescentPsychopharmacology, Antalya, Türkiye, 26 - 30 Nisan 2017, (Özet Bildiri)

7. Overview of bioavailability bioequivalence trials in a phase 1 clinic in Turkey

SEZER Z., İNAL A., ERENMEMİŞOĞLU A., MAZICIOĞLU M. M.

7th World Congress onBioavailability & Bioequivalence: BA/BE Studies Summit, Atlanta, Amerika Birleşik Devletleri, 29 - 31 Ağustos 2016, (Özet Bildiri)

8. Overview of bioavailability bioequivalance clinicl trials in a phase 1 in Turkey

SEZER Z., İNAL A., MAZICIOĞLU M. M., ERENMEMİŞOĞLU A.

7. World Congress on Bioavailability and Bioequivalence:BA/BE Studies Summit, Atlanta, Amerika Birleşik Devletleri, 29 - 31 Ağustos 2016, cilt.8, (Özet Bildiri)

9. Prasugrel effect on In Vitro bleeding time tests in a single dose bioequivalence study

İNAL A., SEZER Z.

7th World Congress onBioavailability & Bioequivalence: BA/BE Studies Summit, Atlanta, Amerika Birleşik Devletleri, 29 - 31 Ağustos 2016, (Özet Bildiri)